Phase II Study, Randomized, Double-Blind, Placebo-Controlled 4-Week Clinical Study, to Evaluate the Efficacy and Safety of MK-7264 in Adult Japanese Participants With Unexplained or Refractory Chronic Cough

Trial Profile

Phase II Study, Randomized, Double-Blind, Placebo-Controlled 4-Week Clinical Study, to Evaluate the Efficacy and Safety of MK-7264 in Adult Japanese Participants With Unexplained or Refractory Chronic Cough

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jul 2018

At a glance

  • Drugs Gefapixant (Primary)
  • Indications Cough
  • Focus Adverse reactions
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 21 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 09 May 2018 Planned End Date changed from 9 Jul 2018 to 7 Jun 2018.
    • 09 May 2018 Planned primary completion date changed from 9 Jul 2018 to 7 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top